Novo Mesto, 11 April (STA) - The supervisory board of pharmaceutical company Krka and its management board proposed a EUR 3.20 gross per dividend on Wednesday. The company said in a press release that that the figure represents a 10.3% increase over last year's dividend.
The supervisors and the management will propose at the AGM scheduled for 4 July that shareholders earmark for dividends EUR 101.84m out of a total of EUR 189.47m in distributable profit.
Just under EUR 43.82m is to go for other reserves from profit and an almost equal amount is to be transferred to next year.
Unaudited business results for last year show that Krka generated EUR 1.33bn in sales revenue, 5.2% more than the year before. Net profit grew by 14% to EUR 174m.
The group's earning before interest and tax (EBIT) increased by 17.1% to EUR 232.7m, while earnings before interest, tax, depreciation and amortisation (EBITDA) were up by about 12% to EUR 343.3m.